Mesenteric traction syndrome – It is not just benign flushing

In all, these findings are very interesting, especially in the context of major abdominal oncological surgery, in which multiple studies have shown that both high postoperative morbidity and severe postoperative complications are associated with a significantly worse short-term and long-term survival [10]. [...]it is clear that MTS, and especially severe MTS, has major clinical implications, and should receive more attention in future research, as interventions attenuating the incidence and impact of severe MTS potentially could lower the postoperative morbidity, as well as potentially improve long-term cancer survival following major abdominal oncological surgery. [...]patients being characterized as having high 30-day postoperative morbidity in the study had significantly higher levels of all four biomarkers, indicating a possible pathophysiologic explanation behind the increased postoperative morbidity in patients developing severe MTS. [...]the study also found that patients developing severe MTS had increased levels of Epinephrine, already at baseline before the first incision, possibly indicating that patients developing severe MTS could belong to a specific phenotype. First of all, such an assessment is at risk of having a low interobserver reproducibility with a risk of different assessors scoring patients differently.